Somatostatin (SS) is a neuropeptide which exists in two forms (SS14 and SS28) and acts as a hormone, a neurotransmitter and an autocrine regulator to inhibit secretion and/or proliferation in endocrine, exocrine, neuronal, immune and tumor cells. SS has been implicated in numerous physiological processes including growth, glucose homeostasis and memory. Moreover, SS analogs are used clinically for the diagnosis and treatment of neuroendocrine tumors and are being evaluated for therapy in several diseases including diabetes mellitus. The biological actions of SS are initiated by binding to a family of five plasma membrane receptors (sst1-sst5) which are coupled to effector enzymes and ion channels via G proteins. Each SS receptor subtype shows a specific tissue and cellular distribution pattern in the brain, the pituitary, the endocrine and exocrine pancreas as well as in neuroendocrine tumors. The goal of this proposal is to elucidate the mechanisms involved in homologous and heterologous regulation of SS receptor subtypes. During the previous award period we demonstrated that the sst2A receptor undergoes rapid phosphorylation following hormone binding as well as upon activation of protein kinase C (PKC). Concomitant with receptor phosphorylation, SS stimulates rapid endocytosis of the sst2A receptor-ligand complex and the rate of this endocytosis is dramatically stimulated by PKC activation. In contrast, the sst1 receptor is minimally endocytosed upon agonist binding. However, the sst1 receptor is also rapidly phosphorylated upon SS treatment and both the sst1 and the sst2A receptors undergo rapid homologous desensitization. The investigator proposes to examine the mechanisms involved in sst receptor desensitization, trafficking, and resensitization and to determine the role of homologous and heterologous receptor phosphorylation in sst receptor regulation. Using biochemical analysis of molecular constructs which include site-specific mutants and receptor deletions and chimeras, the investigator will identify the sites of receptor phosphorylation and define key domains and residues for sst receptor function. Sst receptor regulation will be examined in both transfected cell lines and in cells endogenously expressing the native receptor in order to elucidate the role of the cellular environment in sst receptor desensitization and trafficking.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK032234-16
Application #
6198385
Study Section
Endocrinology Study Section (END)
Program Officer
Abraham, Kristin M
Project Start
1995-07-01
Project End
2005-06-30
Budget Start
2000-07-15
Budget End
2001-06-30
Support Year
16
Fiscal Year
2000
Total Cost
$289,100
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Biology
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Schonbrunn, Agnes (2015) Editorial: Reproducibility in Research: A Cautionary Tale and Lessons Not Learned. Mol Endocrinol 29:1219-21
Schonbrunn, Agnes (2014) Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility. Mol Endocrinol 28:1403-7
Körner, Meike; Waser, Beatrice; Schonbrunn, Agnes et al. (2012) Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol 36:242-52
Waser, Beatrice; Cescato, Renzo; Liu, Qisheng et al. (2012) Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients. Am J Pathol 180:1942-9
Ghosh, Madhumita; Schonbrunn, Agnes (2011) Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation. J Biol Chem 286:13561-73
Kao, Yachu J; Ghosh, Madhumita; Schonbrunn, Agnes (2011) Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists. Mol Endocrinol 25:1040-54
Cescato, Renzo; Loesch, Kimberly A; Waser, Beatrice et al. (2010) Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways. Mol Endocrinol 24:240-9
Liu, Qisheng; Bee, Mark S; Schonbrunn, Agnes (2009) Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation. Mol Pharmacol 76:68-80
Liu, Q; Dewi, D A; Liu, W et al. (2008) Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding. Mol Pharmacol 73:292-304
Schonbrunn, Agnes (2008) Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol 286:35-9

Showing the most recent 10 out of 47 publications